KR910020007A - 3-[1-티아졸리디닐부틸-4-피페라지닐]-1h-인다졸, 이의 제조방법 및 이의 약제로서의 용도 - Google Patents

3-[1-티아졸리디닐부틸-4-피페라지닐]-1h-인다졸, 이의 제조방법 및 이의 약제로서의 용도 Download PDF

Info

Publication number
KR910020007A
KR910020007A KR1019910008144A KR910008144A KR910020007A KR 910020007 A KR910020007 A KR 910020007A KR 1019910008144 A KR1019910008144 A KR 1019910008144A KR 910008144 A KR910008144 A KR 910008144A KR 910020007 A KR910020007 A KR 910020007A
Authority
KR
South Korea
Prior art keywords
compound
hydrogen
piperazinyl
lower alkyl
indazol
Prior art date
Application number
KR1019910008144A
Other languages
English (en)
Other versions
KR100215616B1 (ko
Inventor
제이. 리브 니콜라스
티. 스트러프체프스키 죠셉
지. 저캑 존
보듀 케니쓰
Original Assignee
원본미기재
훽스트-러셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 훽스트-러셀 파마슈티칼즈 인코포레이티드 filed Critical 원본미기재
Publication of KR910020007A publication Critical patent/KR910020007A/ko
Application granted granted Critical
Publication of KR100215616B1 publication Critical patent/KR100215616B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음

Description

3-[1-티아졸리디닐부틸-4-피페라지닐]-1H-인다졸, 이의 제조방법 및 이의 약제로서의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (18)

  1. 하기 일반식(Ⅰ)의 화합물 및 약제학적으로 허용되는 이의 산 부가염, 및 이의 광학적, 기하학적 및 입체이성체, 및 이의 라세미 혼합물.
  3. 상기식에서, R1및 R2는 각각 수소 또는 저급 알킬이거나, 또는 이들이 결합된 탄소원자와 함께 사이클로펜탄, 사이클로헥산 또는 사이클로헵탄 환을 형성하고, R3및 R4는 각각 수소 또는 저급 알킬이거나, 또는 이들이 결합된 탄소원자와 함께 사이클로펜탄, 사이클로헥산 또는 사이클로헵탄 환을 형성하며, R5는 수소, 저급알킬, 알카노일 또는 아로일이고, X는 할로겐, 저급알킬 또는 알콕시이며, m은 0내지 3의 정수이다.
  4. 제1항에 있어서, R3, R4, R5가 각각 수소 또는 저급 알킬이고, X가 할로겐이며, m이 0 또는 1인 화합물.
  5. 제2항에 있어서, R3및 R4가 각각 수소 또는 메틸이고, R5가 수소이며, X가 불소이고, m이 0 또는 1인 화합물.
  6. 제3항에 있어서, R1및 R2가 각각 수소 또는 메틸이거나, 또는 이들이 결합된 탄소원자와 함께 사이클로펜탄 또는 사이클로헥산환을 형성하는 화합물.
  7. 제1항에 있어서,3-(4-(1-[1H-인다졸-3-일]-4-피페라지닐)부틸)-1-티아-3-아자스피로[4,5]데칸-4-온인 화합물.
  8. 제1항에 있어서, 3-(4-[1-(6-플루오로-1H-인다졸-3-일]-4-피페라지닐]부틸)-5-메틸-4-티아졸리디논인 화합물.
  9. 제1항에 있어서, 3-(4-[1-(6-플루오로-1H-인다졸-3-일)-4-피페라지닐]부틸)-1-타아-3-아자스피로[4,5]데칸-4-온인 화합물.
  10. 제1항에 있어서, 3-(4-(1-[1H-인다졸-3-일]-4-피페라지닐)부틸)-1-티아-3-아자스피로[4,5]노난-4-온인 화합물.
  11. 제1항에 있어서, 3-(4-(1-[1H-인다졸-3-일]-4-피페라지닐)부틸)-5,5-디메틸-4-티아졸리디논인 화합물.
  12. 활성성분으로서의 제1항의 화합물 및 약제학적으로 허용되는 이의 담체를 포함하는 약제학적 조성물.
  13. 정신병 치료 활성을 갖는 약제를 제조하기 위한 제1항의 화합물의 용도.
  14. a)하기 일반식(Ⅱ)의 화합물을 하기 일반식(Ⅲ)의 화합물과 반응시켜, R5가 수소인 제1항의 일반식(Ⅰ)의 화합물을 수득하고, 임의로 b)R5가 수소인 제1항의 일반식(Ⅰ)의 화합물을 적합한 알킬화제와 반응시켜, R5가 저급 알킬인 제1항의 일반식(Ⅰ)의 화합물을 수득함을 특징으로 하여, 제1항의 화합물을 제조하는 방법.
  17. 상기식에서, R1, R2, R3, R4, X 및 m은 제1항에서 정의한 바와 같고, R5는 수소 또는 저급알킬이나, 단 일반식(Ⅲ)에서 R5는 수소이다.
  18. ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910008144A 1990-05-21 1991-05-20 3-(1-티아졸리디닐부틸-4-피페라지닐)-1h-인다졸,이의 제조방법및 이를함유하는약제학적조성물 KR100215616B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US526,089 1990-05-21
US07/526,089 US5041445A (en) 1990-05-21 1990-05-21 3-[1-thiazolidinylbutyl-4-piperazinyl]-1H-indazoles

Publications (2)

Publication Number Publication Date
KR910020007A true KR910020007A (ko) 1991-12-19
KR100215616B1 KR100215616B1 (ko) 1999-08-16

Family

ID=24095872

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910008144A KR100215616B1 (ko) 1990-05-21 1991-05-20 3-(1-티아졸리디닐부틸-4-피페라지닐)-1h-인다졸,이의 제조방법및 이를함유하는약제학적조성물

Country Status (23)

Country Link
US (1) US5041445A (ko)
EP (1) EP0458234B1 (ko)
JP (1) JP3161755B2 (ko)
KR (1) KR100215616B1 (ko)
AT (1) ATE178327T1 (ko)
AU (1) AU642243B2 (ko)
CA (1) CA2042982A1 (ko)
CZ (1) CZ280005B6 (ko)
DE (1) DE69131057T2 (ko)
DK (1) DK0458234T3 (ko)
ES (1) ES2130125T3 (ko)
FI (1) FI94757C (ko)
GR (1) GR3030233T3 (ko)
HU (1) HU215845B (ko)
IE (1) IE911708A1 (ko)
IL (1) IL98184A (ko)
MX (1) MX25858A (ko)
NO (1) NO179749C (ko)
NZ (1) NZ238184A (ko)
PL (1) PL165731B1 (ko)
PT (1) PT97720B (ko)
RU (2) RU2038355C1 (ko)
ZA (1) ZA913794B (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81123T1 (de) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
US5801186A (en) 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
CA2157348A1 (en) * 1994-09-01 1996-03-02 Aventis Pharmaceuticals Inc. 3-¬4-(1-substituted-4-piperazinyl)butyl|-4-thiazolidinone and related compounds
AU2007217040A1 (en) * 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-HT6 receptor affinity
US20090069337A1 (en) * 2007-08-15 2009-03-12 Memory Pharmaceuticals Corporation 3' substituted compounds having 5-ht6 receptor affinity
US20100016297A1 (en) * 2008-06-24 2010-01-21 Memory Pharmaceuticals Corporation Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
US20100029629A1 (en) * 2008-07-25 2010-02-04 Memory Pharmaceuticals Corporation Acyclic compounds having 5-ht6 receptor affinity
US20100056531A1 (en) * 2008-08-22 2010-03-04 Memory Pharmaceuticals Corporation Alkyl-substituted 3' compounds having 5-ht6 receptor affinity
JP5760300B2 (ja) 2009-09-10 2015-08-05 株式会社リコー インクジェット用インク組成物材料及びインクジェット用インク組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4100282A (en) * 1972-12-23 1978-07-11 Boehringer Ingelheim Gmbh N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
DE3132916A1 (de) * 1981-08-20 1983-03-03 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4775761A (en) * 1983-08-22 1988-10-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
EP0302423A3 (en) * 1987-08-07 1991-01-09 Hoechst-Roussel Pharmaceuticals Incorporated 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments
ATE81123T1 (de) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
PL290327A1 (en) 1992-05-04
NZ238184A (en) 1993-01-27
CZ280005B6 (cs) 1995-09-13
DE69131057D1 (de) 1999-05-06
DE69131057T2 (de) 1999-09-09
EP0458234A2 (en) 1991-11-27
DK0458234T3 (da) 1999-10-11
FI912401A (fi) 1991-11-22
RU2105765C1 (ru) 1998-02-27
KR100215616B1 (ko) 1999-08-16
FI912401A0 (fi) 1991-05-17
MX25858A (es) 1993-09-01
HU215845B (hu) 1999-04-28
RU2038355C1 (ru) 1995-06-27
HU911697D0 (en) 1991-11-28
ES2130125T3 (es) 1999-07-01
CA2042982A1 (en) 1991-11-22
CZ148091A3 (en) 1993-08-11
JP3161755B2 (ja) 2001-04-25
PL165731B1 (pl) 1995-02-28
IL98184A (en) 1995-03-15
FI94757B (fi) 1995-07-14
ATE178327T1 (de) 1999-04-15
ZA913794B (en) 1992-02-26
IL98184A0 (en) 1992-06-21
EP0458234B1 (en) 1999-03-31
AU7618191A (en) 1991-11-21
NO911921D0 (no) 1991-05-16
FI94757C (fi) 1995-10-25
US5041445A (en) 1991-08-20
HUT61018A (en) 1992-11-30
GR3030233T3 (en) 1999-08-31
PT97720A (pt) 1992-02-28
NO179749B (no) 1996-09-02
EP0458234A3 (en) 1992-09-30
JPH04226979A (ja) 1992-08-17
IE911708A1 (en) 1991-12-04
NO911921L (no) 1991-11-22
NO179749C (no) 1996-12-11
PT97720B (pt) 1998-09-30
AU642243B2 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
KR920021493A (ko) 페녹시페닐 유도체
KR840006633A (ko) 벤족사졸리논 유도체의 제조방법
ATE330930T1 (de) Neue ethylaminderivate
KR910020007A (ko) 3-[1-티아졸리디닐부틸-4-피페라지닐]-1h-인다졸, 이의 제조방법 및 이의 약제로서의 용도
HUT65268A (en) Process for preparation of optically active 2-amino-1,2,3,4-tetrahydro-naphtaline derivatives
KR920016452A (ko) N-(아릴옥시알킬)헤테로아릴-8-아자비시클로[3.2.1]옥탄, 중간체, 이의 제조방법 및 약제로서 이의 용도
HUT50337A (en) Process for producing benzoxazine derivatives and pharmaceutical compositions comprising the compounds
RU93005087A (ru) 3-(тиазолидинилбутил-4-пиперазинил)-ih-индазолы
KR910000652A (ko) (1,2,3,4-테트라하이드로-9-아크리딘이미노) 사이클로헥산 카복실산 및 관련 화합물, 이들의 제조방법 및 약제로서의 용도
KR940005621A (ko) 벤조[b]티오펜-3-일-피페라진. 이의 제조방법 및 약제로서 이의 용도
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
NO173276C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater
ES2004809A6 (es) Procedimiento de obtencion de nuevas 1-(2-(fenilmetil)fenil)piperazinas
SE8005493L (sv) 4-(haftalenyloxi)piperidin-derivat
FI871253A (fi) 1-/3-(2-dialkylaminoetoxi)-2 -tienyl/-3-fenyl-1-propanoner och deras syraadditionssalter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska sammansaettningar.
KR960010649A (ko) 이중환상 옥사졸 및 티아졸 치환된 에테르
KR910000744A (ko) 4,5,5a,6-테트라하이드로-3H-이속사졸로[5,4,3-kl]아크리딘 유도체, 이의 제조 방법 및 약제로서의 이의 용도
GB2017080A (en) Benzothiazepines
DE3370326D1 (en) Substituted 1-((3-(amino)-propoxy)-phenyl)-1-(phenyl)-propan-1-ols, their acid addition salts and quaternary salts, process for their preparation and medicines containing these compounds
KR880007464A (ko) 신규의 치환피페리딘 또는 아제핀, 이것의 제조방법 및 치료적 사용방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20020517

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee